| Literature DB >> 15331424 |
Sergey V Ivanov1, Jerrold M Ward, Lino Tessarollo, Dorothea McAreavey, Vandana Sachdev, Lameh Fananapazir, Melissa K Banks, Nicole Morris, Draginja Djurickovic, Deborah E Devor-Henneman, Ming-Hui Wei, Gregory W Alvord, Boning Gao, James A Richardson, John D Minna, Michael A Rogawski, Michael I Lerman.
Abstract
CACNA2D2 is a putative tumor suppressor gene located in the human chromosome 3p21.3 region that shows frequent allelic imbalances in lung, breast, and other cancers. The alpha2delta-2 protein encoded by the gene is a regulatory subunit of voltage-dependent calcium channels and is expressed in brain, heart, and other tissues. Here we report that mice homozygous for targeted disruption of the Cacna2d2 gene exhibit growth retardation, reduced life span, ataxic gait with apoptosis of cerebellar granule cells followed by Purkinje cell depletion, enhanced susceptibility to seizures, and cardiac abnormalities. The Cacna2d2(tm1NCIF) null phenotype has much in common with that of Cacna1a mutants, such as cerebellar neuro-degeneration associated with ataxia, seizures, and premature death. A tendency to bradycardia and limited response of null mutants to isoflurane implicate alpha2delta-2 in sympathetic regulation of cardiac function. In summary, our findings provide genetic evidence that the alpha2delta-2 subunit serves in vivo as a component of P/Q-type calcium channels, is indispensable for the central nervous system function, and may be involved in hereditary cerebellar ataxias and epileptic disorders in humans.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15331424 PMCID: PMC1618598 DOI: 10.1016/S0002-9440(10)63362-7
Source DB: PubMed Journal: Am J Pathol ISSN: 0002-9440 Impact factor: 4.307